IN188917B - - Google Patents

Info

Publication number
IN188917B
IN188917B IN1106MU2000A IN188917B IN 188917 B IN188917 B IN 188917B IN 1106MU2000 A IN1106MU2000 A IN 1106MU2000A IN 188917 B IN188917 B IN 188917B
Authority
IN
India
Prior art keywords
composition
tpgs
propofol
parenteral administration
present
Prior art date
Application number
Other languages
English (en)
Inventor
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Shilpa Sudhakar Kocharekar
Original Assignee
Bharat Surums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Surums & Vaccines Ltd filed Critical Bharat Surums & Vaccines Ltd
Priority to IN1106MU2000 priority Critical patent/IN188917B/en
Priority to CNB018225349A priority patent/CN1283235C/zh
Priority to MXPA03006054 priority patent/MX228228B/es
Priority to PCT/IN2001/000213 priority patent/WO2002045709A1/en
Priority to AT01999369T priority patent/ATE279917T1/de
Priority to US10/250,420 priority patent/US20040235964A1/en
Priority to CA002432549A priority patent/CA2432549A1/en
Priority to DE60106647T priority patent/DE60106647T2/de
Priority to AU2002217418A priority patent/AU2002217418A1/en
Priority to ES01999369T priority patent/ES2231583T3/es
Priority to RU2003119556/15A priority patent/RU2257892C2/ru
Priority to EP01999369A priority patent/EP1351669B1/en
Publication of IN188917B publication Critical patent/IN188917B/en
Priority to ZA200304981A priority patent/ZA200304981B/en
Priority to HK04107880A priority patent/HK1064954A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN1106MU2000 2000-12-07 2000-12-07 IN188917B (xx)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (xx) 2000-12-07 2000-12-07
DE60106647T DE60106647T2 (de) 2000-12-07 2001-12-05 Klare propofolzusammensetzungen
AU2002217418A AU2002217418A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
PCT/IN2001/000213 WO2002045709A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
AT01999369T ATE279917T1 (de) 2000-12-07 2001-12-05 Klare propofolzusammensetzungen
US10/250,420 US20040235964A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
CA002432549A CA2432549A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
CNB018225349A CN1283235C (zh) 2000-12-07 2001-12-05 清澈稳定的丙泊酚组合物
MXPA03006054 MX228228B (es) 2000-12-07 2001-12-05 Composiciones de propofol claras, estables.
ES01999369T ES2231583T3 (es) 2000-12-07 2001-12-05 Composiciones transparentes de propofol.
RU2003119556/15A RU2257892C2 (ru) 2000-12-07 2001-12-05 Прозрачные стабильные композиции пропофола
EP01999369A EP1351669B1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
ZA200304981A ZA200304981B (en) 2000-12-07 2003-06-26 Clear propofol compositions.
HK04107880A HK1064954A1 (en) 2000-12-07 2004-10-13 Clear propofol compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (xx) 2000-12-07 2000-12-07

Publications (1)

Publication Number Publication Date
IN188917B true IN188917B (xx) 2002-11-23

Family

ID=11097320

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1106MU2000 IN188917B (xx) 2000-12-07 2000-12-07

Country Status (14)

Country Link
US (1) US20040235964A1 (xx)
EP (1) EP1351669B1 (xx)
CN (1) CN1283235C (xx)
AT (1) ATE279917T1 (xx)
AU (1) AU2002217418A1 (xx)
CA (1) CA2432549A1 (xx)
DE (1) DE60106647T2 (xx)
ES (1) ES2231583T3 (xx)
HK (1) HK1064954A1 (xx)
IN (1) IN188917B (xx)
MX (1) MX228228B (xx)
RU (1) RU2257892C2 (xx)
WO (1) WO2002045709A1 (xx)
ZA (1) ZA200304981B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
RS54275B1 (sr) 2002-07-29 2016-02-29 Transform Pharmaceuticals, Inc. Vodeni 2,6-diizopropilfenol farmaceutski sastavi
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
NZ549016A (en) 2004-02-13 2012-03-30 Bioavailability Inc A microemulsion preparation of high concentration propofol for anesthetic uses
BRPI0515181A (pt) * 2004-09-13 2008-07-22 Bharat Serums & Vaccines Ltd composição de óleo-em-água estéril para administração intravenosa, uso de um monoglicerìdeo e processo de preparação de uma composição para administração intravenosa
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
CN107080734B (zh) * 2008-03-20 2020-10-30 维尔恩公司 包含生育酚的peg衍生物的乳剂
AT514764A1 (de) * 2013-09-02 2015-03-15 Sanochemia Ag Beta-Carotin Zubereitung
US11266621B1 (en) * 2014-10-02 2022-03-08 Exela Sterile Medicines Llc Methocarbamol composition and related methods
CN108601732A (zh) * 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
WO2018112512A1 (en) 2016-12-21 2018-06-28 Phosphagenics Limited Process
CN114601800B (zh) * 2021-09-28 2023-07-28 天津瑞普生物技术股份有限公司 一种甲磷丙泊酚钠无菌粉针剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
PE20000264A1 (es) * 1998-02-10 2000-04-11 Gensia Sicor Inc Composicion de propofol que contiene sulfito
PT1143962E (pt) * 1999-01-28 2005-03-31 Kurani Shashikant Prabhudas Solucao parenterica de propofol (2,6-di-isopropilfenol) e 2,5-di-o-metil-1,4;3,6-di-anidro-d-glucitol, como dissolvente
KR100410937B1 (ko) * 1999-06-21 2003-12-18 건일제약 주식회사 프로포폴을 함유하는 혈관주사용 마취제 조성물
IN187686B (xx) * 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
EP1337273A2 (en) * 2000-11-28 2003-08-27 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
HK1064954A1 (en) 2005-02-08
RU2257892C2 (ru) 2005-08-10
EP1351669A1 (en) 2003-10-15
US20040235964A1 (en) 2004-11-25
ZA200304981B (en) 2004-04-23
CN1489457A (zh) 2004-04-14
WO2002045709A1 (en) 2002-06-13
ES2231583T3 (es) 2005-05-16
DE60106647T2 (de) 2005-11-10
CA2432549A1 (en) 2002-06-13
ATE279917T1 (de) 2004-11-15
DE60106647D1 (de) 2004-11-25
MX228228B (es) 2005-06-01
MXPA03006054A (es) 2003-09-10
EP1351669B1 (en) 2004-10-20
CN1283235C (zh) 2006-11-08
AU2002217418A1 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
IN188917B (xx)
AP2002002674A0 (en) Clear Aqueous Anaesthetic composition.
KR960033471A (ko) 나노현탁액용 제약 담체
MXPA05001061A (es) Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol.
IL117889A0 (en) Pharmaceutical compositions containing lipophilic compounds
MY117912A (en) Clear, colorless soap bar with superior mildness, lathering and discolorization resistance
CA2396927A1 (en) Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same
GB2334446A (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
BR0111266A (pt) Sìntese reduzida de derivados de 3,3-diarilpropilamina
CA2429639A1 (en) Stable azithromycin monohydrate
KR960703661A (ko) 알킬폴리글리코시드의 농축 수성 조성물 및 이의 용도
US4481187A (en) Clear liquid skin cosmetic compositions
GR3035613T3 (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
JP2007169232A (ja) 眼科用組成物
EP0616800A2 (en) Odorant compositions with prolonged diffusion
GEP20033046B (en) Parenteral Cisplatin Emulsion
JP2003012492A (ja) 化粧料
AU8008401A (en) Amphotericin b structured emulsion
ATE160938T1 (de) Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung
US5369092A (en) Odorant compositions
NO173635B (no) Fremgangsmaate for fremstilling av en stabil injiserbar opploesning av et antrakinonderivat
DE50107755D1 (en) 3,3-dimethylcyclohexan-derivate
AU2001281717A1 (en) Flavone-containing plant extract solutions having improved storage and heat stability
JPS60184003A (ja) 油中水滴型乳化化粧料